China TB Case Finding Strategic Partnership Program
Johnson & Johnson collaborated with the China CDC to improve TB and RR-TB case detection across several regions in China covering 10 million people.
The initiative was aimed at improving TB case detection and patient finding across several regions of China.
From 2018-2021, Johnson & Johnson collaborated with the National Health Commission (NHC), China CDC and Cepheid to improve TB/MDR-TB patient detection for 10 million individuals in 22 counties of 3 western provinces by introducing quick diagnostic technology and performing medical trainings for local health care providers.
- Western Pacific
- Infectious and Parasitic Disease
SGDs the partnership contributes to
- 3.3: Communicable Diseases & NTDs
- 3.8: Achieve universal health coverage
Infectious and Parasitic Disease
- Drug-Resistant Infections (AMR)